Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FOLR1 positive
i
Other names:
FOLR1, Folate Receptor Alpha, Ovarian Tumor-Associated Antigen MOv18, Adult Folate-Binding Protein, Folate Receptor 1 (Adult), Folate Receptor, Adult, Folate Receptor 1, KB Cells FBP, FR-Alpha, FOLR, FBP, Folate Binding Protein, FRalpha
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2348
Related biomarkers:
Expression
‹
FOLR1 expression (21)
FOLR1 overexpression (6)
FOLR1 positive + TRPV6 positive (1)
FOLR1 expression (21)
FOLR1 overexpression (6)
FOLR1 positive + TRPV6 positive (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FOLR1 positive
Ovarian Cancer
FOLR1 positive
Ovarian Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A1
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Peritoneal Cancer
FOLR1 positive
Peritoneal Cancer
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Fallopian Tube Cancer
FOLR1 positive
Fallopian Tube Cancer
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Ovarian Cancer
FOLR1 positive
Ovarian Cancer
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Ovarian Cancer
FOLR1 positive
Ovarian Cancer
CBP-1008
Sensitive: C3 – Early Trials
CBP-1008
Sensitive
:
C3
CBP-1008
Sensitive: C3 – Early Trials
CBP-1008
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.